R&G PharmaStudies 诺思格
12 significant filings since 29 May 2026: 8 on buyback, 2 on major holder selling and 2 on dividend. The latest, on 14 Aug 2026: 关于提前终止回购公司股份方案暨回购实施结果的公告.
自 29 May 2026 起有 12 份重大公告：buyback 8 份、major holder selling 2 份、dividend 2 份。最新一份（14 Aug 2026）：关于提前终止回购公司股份方案暨回购实施结果的公告。
Price History 价格走势
1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥66.60 · Low 最低 ¥64.28 · −3.57% on the previous close of ¥66.67| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 0 brokers | 0 brokers |
| 7 days ago | 0 brokers | 0 brokers |
| 30 days ago | 0 brokers | 0 brokers |
| 60 days ago | 0 brokers | 0 brokers |
| 90 days ago | 0 brokers | 0 brokers |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 2.41 in Sep 2024 to 2.61 in Feb 2025 (+8.3%). 一致预期从 Sep 2024 的 2.41 变为 Feb 2025 的 2.61 (+8.3%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0.